Oncology · Phase I

Top sponsors

• Chinese Academy of 70 programs
• First People's Hospital 62 programs
• Takeda 49 programs
• United Therapeutics Europe 41 programs
• BEONE MEDICINES AUS 40 programs
• Regeneron UK 34 programs
• Anaxis Pharma 31 programs
• Chongqing Precision Biotech 27 programs
• Janssen-Cilag International N.V 27 programs
• Novartis India 27 programs
• Boehringer Ingelheim 24 programs
• BRIGHT MINDS BIOSCIENCES 23 programs

1. 2138-CL-0101

   Astellas Pharma GmbH

   Gastroesophageal Junction (GEJ) Adenocarcinoma, Gastric Adenocarcinoma, Pancreatic Adenocarcinoma

   phase 1 · other · active

   1 trial →

2. 217228

   GlaxoSmithKline

   Neoplasms

   phase 1 · other · active

   1 trial →

3. 21820

   Bayer AG

   Advanced solid tumors

   phase 1 · other · active

   1 trial →

4. 21948

   Bayer AG

   Advanced solid tumors

   phase 1 · other · active

   1 trial →

5. 22049

   Bayer Australia Ltd

   Advanced metastatic castration-resistant prostate cancer with prostate specific membrane antigen (PSMA) expression

   phase 1 · other · active

   1 trial →

6. 2223-001

   KYOWA KIRIN AUSTRALIA PTY LTD

   T-cell Non-Hodgkin Lymphoma, Cutaneous T-cell lymphoma (CTCL), Peripheral T-cell lymphoma (PTCL)

   phase 1 · other · active

   1 trial →

7. 22231

   Bayer AG

   Advanced solid tumors, Non-small cell lung cancer

   phase 1 · other · active

   1 trial →

8. 22262

   Bayer AG

   hepatocellular carcinoma (HCC)

   phase 1 · other · active

   1 trial →

9. 22676

   Bayer AG

   Advanced solid tumors harboring KRAS G12C mutation

   phase 1 · other · active

   1 trial →

10. 23U-0502

    Disc Medicine

    Metastatic colorectal cancer

    phase 1 · other · active

    1 trial →

11. 2X-121 and dovitinib

    Allarity Therapeutics

    Advanced Solid Tumors

    phase 1 · small molecule · on hold

    1 trial →

12. 2mg INO-5150 and electroporation device CELLECTRA®-5P

    INOVIO PHARMACEUTICALS, INC.

    Prostate Cancer

    phase 1 · mab · completed

    1 trial →

13. 3-dimensional conformal radiation therapy

    United Therapeutics Europe Ltd

    Bladder Cancer

    phase 1 · other · active

    1 trial →

14. 300163

    GlaxoSmithKline

    Neoplasms

    phase 1 · other · active

    1 trial →

15. 4010-01-001

    TESARO Bio Netherlands B.V.

    Patients with Advanced Solid Tumors

    phase 1 · other · active

    1 trial →

16. 42756493BLC1003

    Janssen-Cilag International N.V.

    Localized Bladder Cancer

    phase 1 · other · active

    1 trial →

17. 609A

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Solid Tumors

    phase 1 · small molecule · active

    2 trials →

18. 64264681LYM1001

    Janssen-Cilag International N.V.

    non-Hodgkin lymphoma and chronic lymphocytic leukemia

    phase 1 · other · active

    1 trial →

19. 64264681LYM1002

    Janssen-Cilag International N.V.

    non-Hodgkin lymphoma and chronic lymphocytic leukemia

    phase 1 · other · active

    1 trial →

20. 64619178EDI1001

    Janssen-Cilag International N.V.

    Previously treated lymphoma (blood cancer) or solid tumors and NHL

    phase 1 · other · active

    1 trial →

21. 64Cu-DOTA-TLX592

    Telix Innovations

    Metastatic Prostate Cancer

    phase 1 · small molecule · completed

    1 trial →

22. 67652000PCR1001

    Janssen-Cilag International N.V.

    Metastatic castration-resistant prostate cancer (mCRPC)

    phase 1 · other · active

    1 trial →

23. 67856633LYM1001

    Janssen-Cilag International N.V.

    Non-Hodgkin lymphoma and chronic lymphocytic leukemia

    phase 1 · other · active

    1 trial →

24. 67856633LYM1002

    Janssen-Cilag International N.V.

    Non-Hodgkin lymphoma and chronic lymphocytic leukemia

    phase 1 · other · active

    1 trial →

25. 68-Ga PSMA11

    Telix Innovations

    Prostate Adenocarcinoma

    phase 1 · small molecule · active

    1 trial →

26. 68Ga-AAZTA-NI-093

    The First People's Hospital of Lianyungang

    Prostate Cancer (Adenocarcinoma)

    phase 1 · small molecule · active

    1 trial →

27. 68Ga-BNU-PSMA

    The First People's Hospital of Lianyungang

    Tumor

    phase 1 · other · active

    1 trial →

28. 68Ga-DOTA/NOTA-FAPI-04

    The First People's Hospital of Lianyungang

    Tumor

    phase 1 · small molecule · active

    1 trial →

29. 68Ga-FAPI-Biotin

    The First People's Hospital of Lianyungang

    Tumor

    phase 1 · small molecule · active

    1 trial →

30. 68Ga-JH04

    The First People's Hospital of Lianyungang

    Malignant Neoplasm

    phase 1 · small molecule · active

    1 trial →

31. 68Ga-JH12

    The First People's Hospital of Lianyungang

    Malignant Neoplasm

    phase 1 · small molecule · active

    1 trial →

32. 68Ga-MGS5

    The First People's Hospital of Lianyungang

    Medullary Thyroid Carcinoma

    phase 1 · small molecule · active

    1 trial →

33. 68Ga-NNS309

    Novartis Pharmaceuticals

    Pancreatic Ductal Adenocarcinoma

    phase 1 · small molecule · active

    1 trial →

34. 68Ga-NODAGA-SNA006

    The First People's Hospital of Lianyungang

    Solid Tumor

    phase 1 · mab · completed

    1 trial →

35. 68Ga-PSMA-11

    The First People's Hospital of Lianyungang

    Prostate Cancer

    phase 1 · small molecule · active

    1 trial →

36. 68Ga-Pentixafor

    The First People's Hospital of Lianyungang

    Lymphoma

    phase 1 · small molecule · active

    1 trial →

37. 70218902EDI1001

    Janssen-Cilag International N.V.

    Metastatic Castration-Resistant Prostate Cancer

    phase 1 · other · active

    1 trial →

38. 73841937NSC1001

    Janssen-Cilag International N.V.

    Advanced Non-Small Cell Lung Cancer

    phase 1 · other · active

    1 trial →

39. 74856665AML1001

    Janssen-Cilag International N.V.

    Acute myeloid leukemia or Myelodysplastic syndrome

    phase 1 · other · active

    1 trial →

40. 75276617ALE1002

    Janssen-Cilag International N.V.

    Acute Myeloid Leukemia

    phase 1 · small molecule · active

    1 trial →

41. 78278343PCR1001

    Janssen-Cilag International N.V.

    Metastatic castration-resistant prostate cancer

    phase 1 · other · active

    1 trial →

42. 78278343PCR1003

    Janssen-Cilag International N.V.

    Metastatic Prostate Cancer

    phase 1 · other · active

    1 trial →

43. 87189401PCR1001

    Janssen-Cilag International N.V.

    Advanced Prostate Cancer

    phase 1 · other · active

    1 trial →

44. 88549968MPN1001

    Janssen-Cilag International N.V.

    CALR-mutated Myeloproliferative Neoplasms

    phase 1 · other · active

    1 trial →

45. 88998377LYM1001

    Janssen-Cilag International N.V.

    relapsed or refractory B‑cell non-Hodgkin lymphomas

    phase 1 · other · active

    1 trial →

46. 89853413AML1001

    Janssen-Cilag International N.V.

    Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Types of Myelodysplastic Neoplasms

    phase 1 · other · active

    1 trial →

47. 89862175LUC1001

    Janssen-Cilag International N.V.

    Advanced Solid Tumors

    phase 1 · other · active

    1 trial →

48. 89Zr-DFO-YS5

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 1 · small molecule · active

    1 trial →

Frequently asked questions